Paclitaxel and bevacizumab in first-line treatment for HER2-negative metastatic breast cancer: single-center experience
Lorenzo Livi, Pierluigi Bonomo, Icro Meattini, Gabriele Simontacchi, Daniela Greto, Isacco Desideri, Fiammetta Meacci, Vieri Scotti, Sara Cecchini, Jacopo Nori, Luis Jose Sanchez, Lorenzo Orzalesi, FaVolume:
30
Language:
english
DOI:
10.1007/s12032-012-0434-2
Date:
March, 2013
File:
PDF, 170 KB
english, 2013